etoposide has been researched along with harmine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhargava, SK; Jadala, C; Kamal, A; Nagesh, N; Reddy, TS; Reddy, VG; Sathish, M; Shankaraiah, N; Tokala, R | 1 |
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
1 review(s) available for etoposide and harmine
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
1 other study(ies) available for etoposide and harmine
| Article | Year |
|---|---|
Synthesis and in vitro cytotoxicity evaluation of β-carboline-combretastatin carboxamides as apoptosis inducing agents: DNA intercalation and topoisomerase-II inhibition.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Bibenzyls; Carbolines; Cell Proliferation; DNA Topoisomerases, Type II; DNA, Kinetoplast; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Molecular Structure; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2019 |